摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Propen-1-one, 1-(5-((4-fluorophenyl)methyl)-2-furanyl)-3-hydroxy-3-(1H-tetrazol-5-yl)- | 280571-47-3

中文名称
——
中文别名
——
英文名称
2-Propen-1-one, 1-(5-((4-fluorophenyl)methyl)-2-furanyl)-3-hydroxy-3-(1H-tetrazol-5-yl)-
英文别名
1-[5-[(4-fluorophenyl)methyl]furan-2-yl]-3-hydroxy-3-(2H-tetrazol-5-yl)prop-2-en-1-one
2-Propen-1-one, 1-(5-((4-fluorophenyl)methyl)-2-furanyl)-3-hydroxy-3-(1H-tetrazol-5-yl)-化学式
CAS
280571-47-3
化学式
C15H11FN4O3
mdl
——
分子量
314.27
InChiKey
BJIVDDXSIZXZQH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    23
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    105
  • 氢给体数:
    2
  • 氢受体数:
    7

文献信息

  • Medicinal compositions containing propenone derivatives
    申请人:——
    公开号:US20030171406A1
    公开(公告)日:2003-09-11
    A combination of an integrate inhibitor with an anti-retrovirus active substance and medical compositions containing the same as the active ingredients are found.
    一种将整合抑制剂与抗逆转录病毒活性物质组合使用的医药组合物被发现,该组合物以其作为活性成分。
  • Heteroaromatic derivatives having an inhibitory activity against HIV integrase
    申请人:——
    公开号:US20040002485A1
    公开(公告)日:2004-01-01
    A compound of the formula (I): 1 wherein X is hydroxy, protected hydroxy or optionally substituted amino; Y is —COOR A wherein R A is hydrogen or ester residue, —CONR B R C wherein R B and R C each is independently hydrogen or amide residue, optionally substituted aryl or optionally substituted heteroaryl; and A 1 is optionally substituted heteroaryl; provided that a compound wherein Y and/or A 1 is optionally substituted indol-3-yl is excluded, a tautomer, a prodrug, a pharmaceutically acceptable salt or a hydrate thereof has an inhibitory activity against an integrase.
    式(I)的化合物:其中X为羟基,保护羟基或可选取代的氨基;Y为—COORA,其中RA为氢或酯基残基,—CONRBRC,其中RB和RC各自独立地为氢或酰胺基残基,可选取代的芳基或可选取代的杂芳基;且A1为可选取代的杂芳基;但其中Y和/或A1为可选取代的吲哚-3-基的化合物被排除,其互变异构体、前药、药物可接受的盐或水合物具有对整合酶的抑制活性。
  • Inhibitor for enzyme having two divalent metal ions as active centers
    申请人:——
    公开号:US20040039060A1
    公开(公告)日:2004-02-26
    A pharmaceutical composition for use as an inhibitor of an enzyme having two divalent metal ions as an active center was found. It is possible to inhibit the activity of an enzyme by a compound capable of chelating both of the two divalent metal ions.
    发现了一种用作酶抑制剂的药物组合物,该酶具有两个二价金属离子作为活性中心。能够通过一种化合物来螯合这两个二价金属离子,从而抑制酶活性。
  • AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES
    申请人:SHIONOGI & CO., LTD.
    公开号:EP1142872A1
    公开(公告)日:2001-10-10
    A compound of the formula (I): wherein X is hydroxy, protected hydroxy or optionally substituted amino; Y is COORA wherein RA is hydrogen or ester residue, -CONRBRC wherein RB and RC each is independently hydrogen or amide residue, optionally substituted aryl or optionally substituted heteroaryl; and A1 is optionally substituted heteroaryl; provided that a compound wherein Y and/or A1 is optionally substituted indol-3-yl is excluded, a tautomer, a prodrug, a pharmaceutically acceptable salt or a hydrate thereof has an inhibitory activity against an integrase.
    一种式(I)化合物: 其中 X 是羟基、受保护的羟基或任选取代的氨基;Y 是 COORA(其中 RA 是氢或酯残基)、-CONRBRC(其中 RB 和 RC 各自独立地是氢或酰胺残基)、任选取代的芳基或任选取代的杂芳基;以及 A1 是任选取代的杂芳基;条件是其中 Y 和/或 A1 是任选取代的吲哚-3-基的化合物除外,其同分异构体、原药、药学上可接受的盐或水合物对整合酶具有抑制活性。
  • NOVEL PROCESSES FOR THE PREPARATION OF SUBSTITUTED PROPENONE DERIVATIVES
    申请人:SHIONOGI & CO., LTD.
    公开号:EP1186599A1
    公开(公告)日:2002-03-13
    The present invention provides industrial and commercial processes for the preparation of 2-acyl-5-benzylfuran derivatives, 1,2,4-triazole-3-carboxylic acid ester derivatives and propenone derivatives having anti-HIV activities and usuful crystals thereof. wherein R1, R2 and R4 each is independently hydrogen or the like; A is CR6 or N; R6 is hydrogen or the like; Q is a protecting group; and L is a leaving group.
    本发明提供了制备具有抗 HIV 活性的 2-酰基-5-苄基呋喃衍生物、1,2,4-三唑-3-羧酸酯衍生物和丙 烯酮衍生物及其有用晶体的工业和商业工艺。 其中 R1、R2 和 R4 各自独立地为氢或类似物;A 为 CR6 或 N;R6 为氢或类似物;Q 为保护基团;L 为离去基团。
查看更多